Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor ErlotinibKeith M. Giles(New York University), Peter J. Leedman(University of Western Australia)Molecular Cancer TherapeuticsSeptember 12, 201310.1158/1535-7163.mct-13-0170Cited by 151SaveCiteExport RISWatch citationsRelated PapersRegulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7|PLoS ONE|2012|86microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB|Oncotarget|2016|78